Human osteosarcoma expresses specific ephrin profiles
Open Access
- 31 July 2002
- Vol. 95 (4) , 862-869
- https://doi.org/10.1002/cncr.10749
Abstract
BACKGROUND The molecular mechanisms underlying malignancy of osteosarcoma are unknown. It has been reported that eph receptor protein tyrosine kinases and their ligands, ephrins, are associated with increased tumorigenicity in patients with breast carcinoma and melanoma. The expression and role of eph/ephrins in human osteosarcoma has not yet been characterized. METHODS Ephrin-A1, ephrin-A3, ephrin-A4, ephrin-A5, ephrin-B1, ephrin-B2, and ephrin-B3 mRNA expression was examined by reverse transcription polymerase chain reaction analysis in nine specimens of human osteosarcoma tissue and five human osteosarcoma cell lines. Ephrin-B1 protein expression was detected immunohistochemically in human osteosarcoma tissue. Clinicopathologic correlation was made between the osteosarcoma specimens and their ephrin expression profiles. RESULTS Normal bone specimens, osteosarcoma tissue specimens, and osteosarcoma cell lines expressed a distinct mRNA profile of ephrin-A1, ephrin-A4, and ephrin-B2. A second mRNA profile that included ephrin-A3, ephrin-A5, and ephrin-B1 was expressed by a subset of tumors. The expression of ephrin-B1 was correlated with a poorer clinical prognosis. Ephrin-B1 protein was expressed by osteosarcoma cells and blood vessels. CONCLUSIONS The results of this study suggest that ephrin-B1 expressed by osteosarcoma may be a poor prognostic marker through increased tumorigenicity. Cancer 2002;95:862–9. © 2002 American Cancer Society. DOI 10.1002/cncr.10749Keywords
This publication has 21 references indexed in Scilit:
- Multiple roles of eph receptors and ephrins in neural developmentNature Reviews Neuroscience, 2001
- The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularizationOncogene, 2000
- Eph receptors and ephrin ligands: embryogenesis to tumorigenesisOncogene, 2000
- Up-regulation of ephrin-a1 during melanoma progressionInternational Journal of Cancer, 1999
- Unified Nomenclature for Eph Family Receptors and Their Ligands, the EphrinsCell, 1997
- Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.Journal of Clinical Oncology, 1997
- Eph Receptors and Ligands Comprise Two Major Specificity Subclasses and Are Reciprocally Compartmentalized during EmbryogenesisNeuron, 1996
- A tyrosine kinase profile of prostate carcinoma.Proceedings of the National Academy of Sciences, 1996
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell Biology, 1994
- A Novel Putative Tyrosine Kinase Receptor Encoded by the eph GeneScience, 1987